The crucial role of IL-33 in promoting Treg cell expansion highlights its potential as a target for therapeutic intervention in cancer immunotherapy, emphasizing the importance of understanding and utilizing IL-33 in cancer treatment [138]. The gene discussed is IL33; the disease is cancer.